Brisbane Clinical Trials

The Influenza Study

The study drug is a potential new mRNA vaccine for the influenza virus.

0 nights
1 vaccine visits + 3 follow-up phone calls + 6 visits
  • Study Objective:
  • Develop vaccines to protect against prevalent influenza strains for the year.
  • Understanding Influenza:
  • A respiratory virus with multiple strains, potentially causing annual epidemics.
  • Importance of Prevention:
  • Vaccination can prevent virus spread and reduce flu-related mortality.
  • Clinical Trial Details:
  • Testing vaccine efficacy, overseen by an independent ethics committee.
  • An independent ethics committee has approved this clinical trial.
  • Participants will be reimbursed for their time.

This clinical trial has been approved by an independent ethics committee, and you will be reimbursed for your time.


Biological Sex Male or Female
Age 18 - 49 years old
BMI 18 - 35kg/m²
Medication Stable medications are permitted on a case-by-case basis
Medical conditions Stable medical conditions are permitted on a case-by-case basis
Smoking History Non-smokers or casual smokers (<10 cigarettes/week)